- Wed. May 8th, 2024
One Key Moving Average in Stocks Cleared: Now What? | Mish’s Market Minute
[ad_1] Reserve Chairman Jerome Powell’s speech this past week cautioned against prematurely loosening monetary policy. Powell’s speech reminds us that the Fed is focused on keeping inflation under control. Nonetheless,…
Marriott Intl (NASDAQ:MAR) – Is Nancy Pelosi Betting Big On Hotels? A Look At An Investment The US Speaker Of The House Made
[ad_1] One of the sectors hit hardest during the COVID-19 pandemic was hospitality, which included restaurants and hotels. A member of the U.S. Congress could be betting on the comeback…
CF Acquisition (NASDAQ:CFVI) – ‘Neutrality As A Service’: How This Analyst Says Rumble Could Win The Social Media, Video Market
[ad_1] Ahead of its pending merger with CF Acquisition Corp VI CFVI, an analyst is calling out Rumble’s offering of “neutrality-as-a-service.” The Rumble Analyst: D.A Davidson analyst Tom Forte initiated coverage on…
Cathay Pacific to gradually increase capacity after crew quarantine rules lifted By Reuters
[ad_1] © Reuters. FILE PHOTO: A passenger walks to the First Class counter of Cathay Pacific Airways at Hong Kong Airport in Hong Kong, China April 4, 2018. REUTERS/Bobby Yip…
Spectrum Pharmaceuticals (NASDAQ:SPPI), Immunocore Hldgs (NASDAQ:IMCR), Allakos (NASDAQ:ALLK), AstraZeneca (NASDAQ:AZN), Merck & Co (NYSE:MRK), IMAC Holdings (NASDAQ:BACK), Arcutis Biotherapeutics (NASDAQ:ARQT), Adaptimmune Therapeutics (NASDAQ:ADAP), Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX) – Important Biotech Catalysts For September 9, 2022 – End Of The Day Summary
[ad_1] The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ SPPI lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia.…